Nextcure (NXTC)

Data from SEC filings
Employee count
ESG framework mentions
In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions
Shareholder alignment
Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 24, 2021, NextCure, Inc. (the “Company”) held its 2021 Annual Meeting of Stockholders (the “Annual Meeting”). Set forth below are the matters voted upon at the Annual Meeting and the final voting results for each matter as certified by the inspector of election.

Proposal No. 1: Election of Class II Directors

The Company’s stockholders elected Ellen v. Jones, Ph.D., and Chau Q. Khuong as Class II members of the Company’s Board of Directors (the “Board”), each to serve a three-year term expiring at the Company’s 2024 Annual Meeting of Stockholders, or until such director's earlier death, resignation, or removal from the Board. The results of the votes were as follows:

ForAgainstAbstainBroker Non-Votes
Elaine V. Jones, Ph.D.15,606,2152,167,37913,9934,303,808
Chau Q. Khuong16,317,6161,456,07813,8934,303,808

Proposal No. 2: Ratification of Appointment of Independent Registered Public Accounting Firm

The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021. The results of the vote were as follows:

ForAgainstAbstainBroker Non-Votes